NCT00438490View on ClinicalTrials.gov

The Safety and Efficacy of Recombinant Human Prolactin

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Healthy
Interventions
DRUG

Recombinant Human Prolactin

Trial Locations (1)

02114

Corrine Welt, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00438490 - The Safety and Efficacy of Recombinant Human Prolactin | Biotech Hunter | Biotech Hunter